the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

Piblisher (A-Z)

Category

Insight Pharma Reports Report List

*Report
 
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
Table of Contents Published: 2009/11
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response reviews the problems of insuf-ficient efficacy, side effects, and adverse events associated with the small-molecule and biological drugs available today to treat these disorder ...

Immunotherapies and Vaccines for Nontraditional Indications
Table of Contents Published: 2009/10
This report: Covers a wide range of conditions for which immunotherapies may be effective, including Alzheimer' s disease, addiction, other neurological indications, cardiovascular diseases, hematological disorders, ophthalmic diseases, bone metabolism di ...

Ion Channel Modulator Pipelines: Targets and Agents in Development Overview
Table of Contents Published: 2009/08
Ion Channel Modulator Pipelines: Targets and Agents in Development provides a comprehensive analysis of the ion channel modulator pipeline, breaking it down by company, ion channel type, and therapeutic indication. ...

Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment Overview
Table of Contents Published: 2009/08
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment presents an analysis for the current state of mAb drug development. It identifies more than 250 therapeutic products now in clinical trials, which are largely concentrated in the areas of ...

Data Mining in Drug Development and Translational Medicine Overview
Table of Contents Published: 2009/07
The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. ...

Outsourcing Preclinical Studies to China: Benefits and Challenges Overview
Table of Contents Published: 2009/07
This report describes the impact that language skills and the shortages of key disciplines have on how best to structure preclinical studies in China. Also evaluated are the broad issues such as IP protection and CRO ownership as well as laboratory animal ...

Bioinformatics and Computational Biology: Bottlenecks and Options
Table of Contents Published: 2009/06
The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associat ...

Next-Generation Sequencing: Solving the Genome
Table of Contents Published: 2009/06
Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. ...

Pharmacogenomics: Delivering on the Promise
Table of Contents Published: 2009/06
Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ...

Approaches to Reducing Phase II Attrition
Table of Contents Published: 2009/05
Phase II is the critical development stage in which most clinical attrition occurs. This report focuses on approaches to improving R&D productivity in the pharmaceutical and biotechnology industries and considers: ...

Direct-To-Consumer Genetic Testing: Business Prospects in the United States Overview
Table of Contents Published: 2009/03
The current marketplace for direct-to-consumer (DTC) genetic testing is very dynamic and fluid. At least 42 DTC genetic testing companies have been identified to date, and additional market entrants are likely. Firms marketing and selling genetic tests DT ...

Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
Table of Contents Published: 2009/03
A thorough analysis of recent trends in medicinal chemistry and evaluation of their significance for advancing productivity in drug discovery is presented. ...

Protease Inhibitors: Innovation Drives Drug Pipeline
Table of Contents Published: 2009/02
Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteri ...

Molecular Diagnostics: A Dynamic and Rapidly Broadening Market Overview
Table of Contents Published: 2009/01
The molecular diagnostics market is exploding. New genes and biomarkers are continually being identified and clinically validated, increasing the number of different tests available. The requisite technology and instruments are advancing in tandem. While ...

Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics Overview
Table of Contents Published: 2008/12
Molecular imaging has become an increasingly indispensable tool in life sciences basic research, in translational medicine, and in routine medical diagnostics. ...

Conducting Clinical Trials in Europe: An Insider's Analysis Overview
Table of Contents Published: 2008/12
The clinical trials industry in the developed countries in Europe is a mature and expensive option. Most of these populations are treatment savvy and due to competition patient recruiting can be difficult and time consuming. These considerations have driv ...

European Clinical Trial Site Options: An Insider's Analysis Overview
Table of Contents Published: 2008/12
A vast new opportunity for clinical trials has emerged in Europe as a result of the collapse of the Soviet Union and events during the last decade of the 20th century. ...

Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders Overview
Table of Contents Published: 2008/12
Neurodegenerative diseases are drawing immense interest from the pharmaceutical industry and have inspired heavy competition in the race to introduce the next generation of improved drugs. ...

Stem Cells Come of Age Report Overview
Table of Contents Published: 2008/11
Stem cell science is on the precipice of becoming big business. These enigmatic cells lie at the heart of a fledgling technology with great clinical promise. Stem Cells Come of Age analyzes the current state of stem cell science and technology, and explor ...

GPCRs: Dawn of a New Era?
Table of Contents Published: 2008/10
Current advances in functional screening methodologies, medicinal chemistry, and structure-based drug design have generated large increases in the number and diversity of GPCR drug targets. ...

Immunotherapies and Vaccines for Cancer and Infectious Diseases Report
Table of Contents Published: 2008/10
Immunotherapies and Vaccines for Cancer and Infectious Diseases reviews current pharmacological options for 12 major cancers being targeted by companies developing cancer immunotherapies or vaccines. While a large number of drugs are available for these p ...

Obesity Drug Pipeline: Developing Therapies for a Complex Disease
Table of Contents Published: 2008/09
The prevalence of overweight and obesity is increasing at an alarming rate worldwide, driven by social and economic changes. Obesity is involved in the pathogenesis of major diseases, especially diabetes and cardiovascular disease. Yet there are no suffic ...

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
Table of Contents Published: 2008/08
Recent developments reflect the explosion in the number of kinase inhibitors that have entered clinical development in the past few years ...

Strategic Management of Resources and Portfolios: Structuring Risk to Maximize Opportunity in Pharmaceutical R&D
Table of Contents Published: 2008/08
As a company develops its business, resources will always be limited and risk will always be involved. This is especially true for companies operating in the high-risk life science industry. To stay on top of the changing pharmaceutical R&D environment, c ...

Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Table of Contents Published: 2008/07
The current crisis in antibiotic R&D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, drug-resistant bacterial strains. ...

Cancer Biomarkers: Adoption Is Driving Growth
Table of Contents Published: 2008/07
Cancer Biomarkers: Adoption Is Driving Growth explores the various applications for cancer biomarkers across the healthcare spectrum by presenting the successful adoption of specific biomarkers. These applications include the identification of novel thera ...

Blood-Brain Barrier: Bridging Options for Drug Discovery and Development
Table of Contents Published: 2008/05
CNS diseases are a major focus of the pharmaceutical industry, with CNS drugs representing some of its most successful products. These include Pfizer' s Zoloft (sertraline, for treatment of depression and certain types of anxiety disorders), Lilly' s Cymb ...

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
Table of Contents Published: 2008/05
At least 50 companies have a claimed product or service relevant to cardiotoxicity screening, of which 29 have some clear focus on proarrhythmic cardiotoxicity or ion channel screening. ...

Systems Biology: A Disruptive Technology
Table of Contents Published: 2008/05
This report focuses on the current and future applications of Systems Biology in drug discovery, specifically in pinpointing optimal individual targets, and combinations of targets, to overcome metabolic pathway redundancies, leading to efficacious and sa ...

INFLAMMATORY DIRECTIONS: Strategies for Six Diseases with Unmet Needs
Table of Contents Published: 2008/04
This report provides Inflammatory Directions Market Research ,Trends, Analysis. ...

MicroRNAs: Commercial Products on the Horizon
Table of Contents Published: 2008/03
With the first diagnostics set to debut within a year, the new research and development field of microRNAs is beginning to reveal its potential. ...

Epigenetics: Technologies, Applications, and the Commercial Landscape
Table of Contents Published: 2008/02
This report provides Epigenetics Technologies, Applications,& Commercial Landscape Market Research ,Trends, Analysis. ...

Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
Table of Contents Published: 2008/02
This report provides Translational Medicine Multiplex Assays Market Research, Trends, Analysis. ...

Molecular Imaging in Drug R&D and Medical Practice: Technologies, Applications, Markets
Table of Contents Published: 2008/01
The rapidly emerging field of molecular imaging is poised to open new vistas for basic researchers, scientists working in drug discovery and development, and physicians. ...

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
Table of Contents Published: 2008/01
Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets provides a cutting-edge review of the challenges, achievements, and perspectives that characterize the inseparable therapeutic triad of ophthalmological pharmacology, surgery of ...

Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
Table of Contents Published: 2007/11
This report provides a thorough discussion of the many companies involved in molecular diagnostics and their commercial products either on the market or in development for these applications. ...

Adaptive Clinical Trials: Innovations in Trial Design, Management, and Analysis
Table of Contents Published: 2007/09
The pharma industry is gradually coming to realize that the classically structured clinical trial does not offer enough flexibility to make use of continuously emerging knowledge that is generated as the trial progresses. This report is a comprehensive as ...

Backup Compound Strategies: Best Practices for Reducing Phase II Risk
Table of Contents Published: 2007/09
This report provides Backup Compound Strategies Market Research, Trends, Analysis. ...

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
Table of Contents Published: 2007/08
A growing number of companies and academic groups are reporting impressive progress in commercializing new sequencing platforms that offer orders of magnitude of improved throughput and cost. The prospect of routine, personalized genome sequencing is sudd ...

Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
Table of Contents Published: 2007/07
In recent years, there has been an explosion in predictive technologies to help researchers select only the most promising candidates for clinical development. The need for such tools is driven by the disastrous economic consequences of late-stage failure ...

Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Table of Contents Published: 2007/06
This report focuses on disease-related biomarkers, those related to disease screening, prognosis, and stratification-more specifically, disease-related molecular biomarkers. ...

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
Table of Contents Published: 2007/05
This new report from CHI' s Insight Pharma Reports assesses the commercial opportunities and provides the information and guidance that companies need to steer clear of the pitfalls in combination drug/diagnostic R&D. ...

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
Table of Contents Published: 2007/05
This report provides Diabetic Complications Market Researchm Trends, Analysis. ...

High Content Analysis: Technologies, Applications, Market Analysis
Table of Contents Published: 2007/05
This report provides High Content Market Research, Trends, Analysis. ...

Metabolic and Inflammatory Disease R&D: An Assessment of 5 Highly Promising Therapeutic Classes
Table of Contents Published: 2007/04
Metabolic and Inflammatory Disease R&D: An Assessment of 5 Highly Promising Therapeutic Classes details and assesses the efforts of more than 20 major pharmaceutical companies and more than 25 additional companies to manage the development of potential me ...

Delivery Technologies for Protein Therapeutics: Assessment and Outlook
Table of Contents Published: 2007/03
This report provides Protein Therapeutics Market Research, Trends, Analysis. ...

Cytokine Therapies and Inhibitors: A Vibrant Pipeline and Active Approved Market
Table of Contents Published: 2007/02
Cytokine Therapies and Inhibitors: A Vibrant Pipeline and Active Approved Market, a new CHI Advances Report, takes a comprehensive look at the full range of cytokine therapies and inhibitors, from products in research and development to products already a ...

Biomarker SOPs: Getting Optimum Value from Your Biomarker Programs
Table of Contents Published: 2007/01
As biomarkers have grown in importance throughout the pharma R&D cycle, managers have moved from informal, intuitive ways of dealing with biomarker discovery and implementation to more formal procedures. ...

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
Table of Contents Published: 2006/11
This report provides the research about Cancer Immunotherapies & Vaccines Market. ...

Outlook for Predictive Safety Technologies
Table of Contents Published: 2006/11
This report provides Predictive Safety Technologies Market Research, Trends, Analysis. ...

Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
Table of Contents Published: 2006/10
This report provides Neurotherapeutics Market Research, Trends, Analysis. ...

Specialty Pharmaceuticals Driving Industry Growth into the Next Decade
Table of Contents Published: 2006/10
This report provides the research about Specialty Pharmaceuticals Driving Industry Market. ...

Comparative Genomic Hybridization: Current State and Future Directions
Table of Contents Published: 2006/09
Comparative Genomic Hybridization: Current State and Future Directions profiles the major vendors and their CGH product offerings. The report concludes with in-depth interviews with experts in industry and academia, providing authoritative insight into th ...

Infectious Diseases: R&D Challenges and Market Drivers
Table of Contents Published: 2006/09
This report provides the research about Infectious Diseases Market. ...

Proteomics: Current State and Future Directions
Table of Contents Published: 2006/09
This report provides the research about Proteomics Current State & Future Directions Market. ...

Antiviral Therapeutics: Pipelines and Competitive Dynamics
Table of Contents Published: 2006/07
Antiviral Therapeutics: Pipelines and Competitive Dynamics assesses the compounds, the clinical data, the companies, and the market-shifting developments in the antiviral therapeutic category. ...

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes and COPD
Table of Contents Published: 2006/06
Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD is a survey of emerging targets in these important diseases. ...

Kinase Therapeutics:A Wealth of Targets Sparks a Highly Active Market
Table of Contents Published: 2006/05
Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market reviews the considerable array of drug development efforts directed at kinases. ...

Microdosing in Translational Medicine: Pros and Cons
Table of Contents Published: 2006/05
Microdosing in Translational Medicine: Pros and Cons evaluates this innovative approach to investigating candidate molecules. ...

Multiplex Assays: Technologies, Applications And Markets
Table of Contents Published: 2006/04
This report provides insightful and innovative business strategies and market acumen for companies striving to capitalize on the many evolving opportunities in this profitable but challenging business sector. ...

The Impact of Genomics Clinical Trials and Medical Practice
Table of Contents Published: 2006/04
The Impact of Genomics on Clinical Trials and Medical Practice evaluates the potential of clinical genomics to transform drug development and the practice of medicine. ...

Sleeper Diseases: Forecast and Assessment of Neglected Disease Market Opportunities
Published: 2006/02
Sleeper diseases comprise a broad spectrum of increasingly recognized conditions with various degrees of neuropsychiatric involvement. Many of these conditions are now clearly defined, earning them increasing acceptance as real disorders that can and shou ...

Oncogenomics: The Future of Cancer Care
Table of Contents Published: 2006/01
Oncogenomics: The Future of Cancer Care analyzes the key advances and challenges associated with translating research efforts into successful, clinically meaningful therapeutic products. The emergence of oncogenomics promises a new era of cancer care. ...

A New Paradigm for Clinical Development: The Clinical Trial in 2015
Table of Contents Published: 2005/12
A New Paradigm for Clinical Development: The Clinical Trial in 2015 outlines an innovative and imaginative strategy for reinventing clinical development ...

Molecular Diagnostics: New Growth, New Markets
Table of Contents Published: 2005/11
Molecular Diagnostics: New Growth, New Markets highlights current trends in the molecular diagnostic industry and the major prospects and challenges ahead. ...

RNAi Therapeutics: Challeges in Drug Development and Delivery
Table of Contents Published: 2005/11
Interfering RNA (RNAi) offers tremendous therapeutic promise to silence genes that give rise to bad, proteins and, therefore, disease. ...

Cancer Diagnostics: Technology and Business Trends
Table of Contents Published: 2005/10
Cancer Diagnostics: Technology and Business Trends examines the current status of in vivo imaging applications and in vitro cancer diagnostic tests, ...

Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Developement
Table of Contents Published: 2005/10
Combination Therapies: Benefits and Challenges in Drug, ...

Hematological Cancer Therapeutics: Pipelines and Competition
Table of Contents Published: 2005/09
Blood cancers include leukemia, lymphoma, and multiple myeloma. Collectively, ...

Pharmaceutical R&D Productivity: The Path to Innovation
Table of Contents Published: 2005/09
examines the convergence of scientific, regulatory, social, political, and economic factors that are inhibiting the development of new molecular entities (NMEs), resulting in the current discovery deficit that threatens the pharmaceutical industry and the ...

Powering Discovery through Target Evaluation: Moving Beyond the Validation Paradigm
Table of Contents Published: 2005/08
The shift from traditional to genomics-and proteomics-based drug discovery has fundamentally changed the way researchers view the subject of targets. ...

Nutrigenomics: Impacts on Markets, Diets, and Health
Table of Contents Published: 2005/07
This report provides the scientific and business communities with an overview of what nutrigenomics?the tailoring of diet to personal genetics?currently is and what it might be in the future. ...

Pharmacodiagnostics: Technologies, Competition, & Market Models
Table of Contents Published: 2005/07
Pharmacodiagnostics: Technologies, Competition, and Market Models examines the reasons why the business environment of pharmaceuticals is changing in favor of pharmacodiagnostics, and describes market models that are likely to emerge as the pharmaceutical ...

Inflammatory Disease Therapeutics: Pipelines and Competitive Dynamics
Table of Contents Published: 2005/06
The complexity of the immune system provides both opportunity and challenge for those in the pharmaceutical industry trying to manipulate it. ...

Cardiovascular Diagnostics: Key Developments in Technologies and Markets
Table of Contents Published: 2005/05
Cardiovascular diseases continue to be an enormous medical and cost burden on the health care system. As the rapidly aging population drives an increase in the incidence and prevalence of heart disease, the need for early detection and intervention will e ...

Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D
Table of Contents Published: 2005/03
The cost to discover and develop a drug is increasing dramatically; however, the number approved new drug products on the decline. ...

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
Table of Contents Published: 2005/03
CNS disorders affect a vast patient population and represent a huge area of unmet therapeutic need. In the United States alone, Alzheimerfs disease (AD), Parkinsonfs disease (PD), and amyotrophic lateral sclerosis (ALS) afflict more than 6.5 million peo ...

2015: Strategic Considerations for the U.S. Pharmaceutical Industry
Table of Contents Published: 2005/02
The pharmaceutical industry thrives on innovative products and clinically differentiated medicines that can create real value. ...

Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast
Table of Contents Published: 2005/01
Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast is a thorough evaluation of marketed therapies and drugs in development for obesity, dyslipidemia, type 2 diabetes, and hypertension. ...

Toxicogenomics and Predictive Toxicology: Market and Business Outlook
Table of Contents Published: 2004/12
Toxicogenomics and Predictive Toxicology: Market and Business Outlook addresses the significant need and potential for predictive toxicology in drug development. ...

Microarrays: Technologies, Applications, Markets
Table of Contents Published: 2004/11
Microarrays: Technologies, Applications, Markets evaluates the competitive picture, growth trends, and deal-making activities in this dynamic and rapidly-growing market. ...

Molecular Imaging Comes of Age: Applications and Impacts in Discovery, Clinical Trials, and Medical Practice
Table of Contents Published: 2004/10
Molecular Imaging Comes of Age: Applications and Impacts in Discovery, Clinical Trials, and Medical Practice provides insight into the technologies that will impact healthcare over the next five years from early research to the delivery of care. ...

New Directions in Monoclonal Antibodies: Technologies, Markets, Competition
Table of Contents Published: 2004/10
New Directions in Monoclonal Antibodies: Technologies, Markets, Competition reviews the broad drug development effort that is focused on bringing improved mAb-based products to the market, including those used for drug discovery research, in vivo diagnost ...

Successful Outsourcing of Pharmaceutical R&D: Trends and Strategies
Table of Contents Published: 2004/09
In the battle against declining productivity, pharma companies have generally responded by restructuring the R&D organization, investing in technology tools and platforms, and entering into mergers and deals. ...

Model Animal Systems: Emerging Applications and Commercial Opportunities in Drug Discovery and Development
Table of Contents Published: 2004/06
As a result, there has been a surge in the development of such models as well as in the number of commercial ventures built around model organisms. ...

Clinical Genomics: The Impact of Genomic Technology on Clinical Trials and Medical Practice
Table of Contents Published: 2004/05
This report assesses the challenges and future prospects for incorporating genomics technologies into standard clinical practice. ...

Molecular Diagnostics: Technological Advances Fueling Market Expansion
Table of Contents Published: 2003/11
The molecular diagnostics market is the fastest-growing segment of the in vitro diagnostics industry. ...

Successful Pharmacogenomics Business Models
Table of Contents Published: 2003/11
This report provides a theoretical framework to evaluate pharmacogenomics initiatives within pharmaceutical companies. ...

Post-Genomic Target Validation: Next-Generation Approaches and Tools for Optimizing Target Selection
Table of Contents Published: 2003/09
After decades of focusing on a few hundred relatively well-characterized therapeutic targets, drug developers are now finding that the genomics revolution has presented them with the opposite dilemma: ...

Cancer Genomics: Revolutionizing Treatment and Reshaping Markets Through Targeted Therapies
Table of Contents Published: 2003/08
This report is a useful summary to marketing and licensing departments that need to quickly assess the latest developments in cancer genomics. ...

GPCRs: Mining the Richest Vein in Drug Discovery
Table of Contents Published: 2003/05
This report describes the current state-of-the-art in both GPCR screening and downstream technology, as well as the various strategies being employed by firms in the field to advance their technologies and products. Also included are capsules of key compe ...

Life Sciences Informatics: From Data to Drugs
Table of Contents Published: 2003/04
Informatics will be one of the keys to success for companies applying high-throughput genomic tools to drug discovery and development. ...

Proteomics Survey 2003
Table of Contents Published: 2003/04
The report examines all major aspects of proteomics, including protein separation, ultrafiltration, 1D and 2D gel electrophoresis, liquid chromatography, capillary electrophoresis, mass spectrometry, protein informatics, protein arrays, protein quantifica ...

Advances in Lead Optimization Accelerating Drug Discovery and Development
Table of Contents Published: 2003/02
This report evaluates the many efforts that are under way to make lead optimization less time-consuming and linear. A compound that fails near the end of the process can potentially waste significant resources; the ability to optimize a compound for sever ...

Proteomics Survey Report 2003
Table of Contents Published: 2003/02
The report examines all major aspects of proteomics, including protein separation, ultrafiltration, 1D and 2D gel electrophoresis, liquid chromatography, capillary electrophoresis, mass spectrometry, protein informatics, protein arrays, protein quantifica ...

Prospects for Commercialization of Human Monoclonal Antibodies
Table of Contents Published: 2002/12
This report, based on half a dozen interviews with leading experts in the field, examines business and technological trends fueling the use of monoclonal antibodies in drug discovery and development, and discusses how these trends will influence the outlo ...

Targeting RNA in Drug Development: Emerging Tools and Therapeutics
Table of Contents Published: 2002/12
Based on interviews with leading experts in the field, this report examines the technological and business trends driving growth in RNA therapeutics. The state-of-the-art in antisense, ribozymes, aptamers, spiegelmers, RNA interference and numerous other ...

*Top


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.